期刊文献+

阿托伐他汀对冠心病患者颈动脉内-中膜厚度的影响 被引量:6

The influence of atorvastatin on intimal-medial thickness of carotid artery in patients with coronary artery disease
下载PDF
导出
摘要 目的:应用高频超声观察冠心病(CAD)患者,经阿托伐他汀治疗后对颈动脉内-中膜(IMT)的改善作用。方法:经冠脉造影(CAG)确诊为CAD并伴有颈动脉粥样硬化患者59例,利用高频超声血管技术检测阿托伐他汀对CAD患者治疗前后颈动脉最厚处和最薄处IMT。结果:阿托伐他汀组治疗2年后,冠心病患者颈动脉IMT最厚处和最薄处与治疗前相比均无显著性改变(P>0.05);常规治疗组治疗2年后,颈动脉IMT最厚处与治疗前相比无显著性改变(P>0.05),IMT最薄处显著增厚(P<0.05)。结论:阿托伐他汀具有稳定斑块、延缓粥样硬化斑块进展的作用。 Objective :To observe the effect of atorvastatin on intimal - medial thickness (IMT) of carotid artery in patients with coronary artery disease (CAD) by high - frequency ultrasonic imaging. Methods: A total of 59 patients with CAD and carotid artery artherosclerosis diagnosed by coronary angiography (CAG) and high - frequency ultrasound were submitted to this study. High - frequency ultrasonic imaging was used to detect the changes of carotid artery IMT after administration of atorvastatin. Results: After atorvastatin therapy for 2 years, both thickest and thinnest IMT of carotid artery in CAD patients had no significant change ( P 〉 0.05 ). In conventional therapy group, the thickest IMT of carotid artery had no significant change (P 〉 0.05 ), but the thinnest IMT thickened significantly (P 〈 0.05 ). Conclusion: Atorvastatin is effective to stabilize the plaque and retard the development of atherosclerosis.
出处 《西北国防医学杂志》 CAS 2007年第2期104-106,共3页 Medical Journal of National Defending Forces in Northwest China
基金 陕西省科技攻关基金资助项目(2006K13-G1)
关键词 超声波诊断 内-中膜厚度 冠心病 Ultrasonography Intimal- medial thickness Atorvastatin Coronary artery disease
  • 相关文献

参考文献5

  • 1程纯,吴士尧.普伐他汀对冠心病患者颈动脉粥样斑块的影响[J].中国临床药学杂志,2001,10(3):140-143. 被引量:25
  • 2O'Leary DH,Polak JF,Kponmal PA,et al.Carotid arteryintima and media thickness as a risk factor for myocardial infarction and stroke in older adults[ J ].N Engl J Med,1999,340(1):14 -22.
  • 3Harsch M,Bracsen JH,N iendarf A.Effects of low-dose pravastatin sodium on plasma cholesterol levels and aortic atherosclerosis of heterozygous WHHL rabbits fed a low cholesterol (0.03%) enriched diet for one year[ J ].Atherosclerosis,1997,128 (2):139-147.
  • 4Nissen SE,Tuzcu EM,Schoenhagen P,et al.Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis:a randomized controlled trial[J].JAMA,2004,291 (9):1071-1080.
  • 5Schwartz GG,Olsson AG,Ezekowitz MD,et al.Effect of atorvastain on early recurrent ischemic events in acute coronary syndrome:the MIRACLE study.A randomized controlled trial[J].JAMA,2001,285(13):1711-1718.

二级参考文献1

共引文献24

同被引文献60

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部